293 related articles for article (PubMed ID: 32666928)
1. Amyopathic and anti-TIF1 gamma-positive dermatomyositis: analysis of a monocentric cohort and proposal to update diagnostic criteria.
Didona D; Juratli HA; Scarsella L; Keber U; Eming R; Hertl M
Eur J Dermatol; 2020 Jun; 30(3):279-288. PubMed ID: 32666928
[TBL] [Abstract][Full Text] [Related]
2. Autoantibody to transcriptional intermediary factor-1β as a myositis-specific antibody: clinical correlation with clinically amyopathic dermatomyositis or dermatomyositis with mild myopathy.
Ueda-Hayakawa I; Hamaguchi Y; Okiyama N; Motegi S; Yamaoka T; Miyake S; Higashi A; Okamoto H; Takehara K; Fujimoto M
Br J Dermatol; 2019 Apr; 180(4):881-887. PubMed ID: 30120913
[TBL] [Abstract][Full Text] [Related]
3. Paraneoplastic Dermatomyositis in a Patient with Metastatic Gastric Carcinoma.
Pozharashka J; Dourmishev L; Rusinova D; Balabanova M; Miteva L
Acta Dermatovenerol Croat; 2020 Aug; 28(2):120-122. PubMed ID: 32876041
[TBL] [Abstract][Full Text] [Related]
4. Inflammatory Myopathies with Cutaneous Involvement: from Diagnosis to Therapy.
Dourmishev LA
Folia Med (Plovdiv); 2017 Mar; 59(1):7-13. PubMed ID: 28384112
[TBL] [Abstract][Full Text] [Related]
5. Dermatomyositis in six patients without initial muscle involvement.
Krain L
Arch Dermatol; 1975 Feb; 111(2):241-5. PubMed ID: 1078762
[TBL] [Abstract][Full Text] [Related]
6. A systematic review of adult-onset clinically amyopathic dermatomyositis (dermatomyositis siné myositis): a missing link within the spectrum of the idiopathic inflammatory myopathies.
Gerami P; Schope JM; McDonald L; Walling HW; Sontheimer RD
J Am Acad Dermatol; 2006 Apr; 54(4):597-613. PubMed ID: 16546580
[TBL] [Abstract][Full Text] [Related]
7. Correlation between tests of muscle involvement and clinical muscle weakness in polymyositis and dermatomyositis.
Tymms KE; Beller EM; Webb J; Schrieber L; Buchanan WW
Clin Rheumatol; 1990 Dec; 9(4):523-9. PubMed ID: 2088650
[TBL] [Abstract][Full Text] [Related]
8. Clinical significance of serum levels of anti-transcriptional intermediary factor 1-γ antibody in patients with dermatomyositis.
Ikeda N; Yamaguchi Y; Kanaoka M; Ototake Y; Akita A; Watanabe T; Aihara M
J Dermatol; 2020 May; 47(5):490-496. PubMed ID: 32103537
[TBL] [Abstract][Full Text] [Related]
9. Amyopathic dermatomyositis.
Saoud B; Allali F; Hassouni NH
Joint Bone Spine; 2006 May; 73(3):318-20. PubMed ID: 16253536
[TBL] [Abstract][Full Text] [Related]
10. [Comparison of clinical and immunological features between clinically amyopathic dermatomyositis and typical dermatomyositis].
Gan YZ; Li YH; Zhang LH; Ma L; He WW; Jin YB; An Y; Li ZG; Ye H
Beijing Da Xue Xue Bao Yi Xue Ban; 2020 Dec; 52(6):1001-1008. PubMed ID: 33331305
[TBL] [Abstract][Full Text] [Related]
11. [Classic/amyopathic dermatomyositis].
Vilas AP; Fiúza T
Acta Med Port; 2000; 13(5-6):287-94. PubMed ID: 11234494
[TBL] [Abstract][Full Text] [Related]
12. Specific autoantibodies in dermatomyositis: a helpful tool to classify different clinical subsets.
Merlo G; Clapasson A; Cozzani E; Sanna L; Pesce G; Bagnasco M; Burlando M; Parodi A
Arch Dermatol Res; 2017 Mar; 309(2):87-95. PubMed ID: 27928683
[TBL] [Abstract][Full Text] [Related]
13. Serum KL-6 level is a prognostic marker in patients with anti-MDA5 antibody-positive dermatomyositis associated with interstitial lung disease.
Ye Y; Fu Q; Wang R; Guo Q; Bao C
J Clin Lab Anal; 2019 Oct; 33(8):e22978. PubMed ID: 31301087
[TBL] [Abstract][Full Text] [Related]
14. Amyopathic dermatomyositis.
Olsen NJ; Park JH; King LE
Curr Rheumatol Rep; 2001 Aug; 3(4):346-51. PubMed ID: 11470054
[TBL] [Abstract][Full Text] [Related]
15. Comparison of cytokine profiles between anti-ARS antibody-positive interstitial lung diseases and those with anti-MDA-5 antibodies.
Asakawa K; Yoshizawa K; Aoki A; Kimura Y; Tanaka T; Ohashi K; Hayashi M; Kikuchi T; Sato S; Takada T
Clin Rheumatol; 2020 Jul; 39(7):2171-2178. PubMed ID: 32056068
[TBL] [Abstract][Full Text] [Related]
16. Redefining dermatomyositis: a description of new diagnostic criteria that differentiate pure dermatomyositis from overlap myositis with dermatomyositis features.
Troyanov Y; Targoff IN; Payette MP; Raynauld JP; Chartier S; Goulet JR; Bourré-Tessier J; Rich E; Grodzicky T; Fritzler MJ; Joyal F; Koenig M; Senécal JL
Medicine (Baltimore); 2014 Nov; 93(24):318-332. PubMed ID: 25500701
[TBL] [Abstract][Full Text] [Related]
17. A systematic review of juvenile-onset clinically amyopathic dermatomyositis.
Gerami P; Walling HW; Lewis J; Doughty L; Sontheimer RD
Br J Dermatol; 2007 Oct; 157(4):637-44. PubMed ID: 17596148
[TBL] [Abstract][Full Text] [Related]
18. [Interstitial lung disease-associated with amyopathic dermatomyositis and anti-MDA5 autoantibodies].
Gerfaud-Valentin M; Ahmad K; Piegay F; Fabien N; Raphanel B; Cordier JF; Cottin V
Rev Mal Respir; 2014 Nov; 31(9):849-53. PubMed ID: 25433590
[TBL] [Abstract][Full Text] [Related]
19. Amyopathic dermatomyositis or dermatomyositis-like skin disease: retrospective review of 16 cases with amyopathic dermatomyositis.
Cao H; Parikh TN; Zheng J
Clin Rheumatol; 2009 Aug; 28(8):979-84. PubMed ID: 19294477
[TBL] [Abstract][Full Text] [Related]
20. Two young-adult female cases of dermatomyositis with antibodies for transcriptional intermediary factor 1-γ.
Matsuura E; Ishiguro N; Katsumata Y; Urano W; Yamanaka H; Kondo M; Kuwana M; Kaji K; Hamaguchi Y; Fujimoto M; Kawashima M
Eur J Dermatol; 2012; 22(5):668-71. PubMed ID: 22992252
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]